JPM | Pulse Check: ALNY and BMY. ALNY/ATTR-CM Debrief Call at 2pm

Research evidence excerpt

JPM | Pulse Check: ALNY and BMY. ALNY/ATTR-CM Debrief Call at 2pm

Elif Korkmaz - Specialist Sales - US Healthcare AC North America Specialist Sales J P M O R G A Nelif.korkmaz@jpmorgan.com

J.P. Morgan Securities LLC 30 July 2026

MedTech Research:

Robbie Marcus robert.j.marcus@jpmorgan.com+1 212 622 6657

Allen Gong allen.gong@jpmorgan.com+1 212 622 9520

Lilia-Celine Lozada lilia-celine.b.lozada@jpmchase.com +1 212 622 1019

Rohin Patel rohin.patel@jpmchase.com +1 212 622 1297

Life Science Tools & Diagnostics:

Casey Woodring casey.woodring@jpmchase.com+1 212 622 9074

Marta Nazarovets marta.nazarovets@jpmorgan.com+1 212 622 6046

Jaden Rismay jaden.rismay@jpmchase.com+1 212 622 8479

Sebastian Sandler sebastian.sandler@jpmchase.com +1 646 538 9821

Disclaimers:

This communication is intended for institutional & professional clients only. Do not forward to any non-institutional clients. You are receiving this email because you are a client of J.P. Morgan. If you would

like to stop receiving the Healthcare Sector Specialist Commentary please email Elif Korkmaz at elif.korkmaz@jpmorgan.com.

FOR INSTITUTIONAL & PROFESSIONAL CLIENTS ONLY – NOT INTENDED FOR RETAIL CUSTOMER USE

This material has been prepared by J.P. Morgan Sales and Trading personnel and is not the product of J.P. Morgan’s Research Department. It is not a research report and is not intended as such. This

material is provided for informational purposes only and is subject to change without notice. It is not intended as research, a recommendation, advice or an offer or a solicitation to buy or sell any financial

product or service, or to be used in any way for evaluating the merits of participating in any transaction. Please consult your own advisors regarding the legal, tax, accounting or other consequences of any